Camber Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Camber Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-500,000	Closed	-$19.5M	–	38
2018 Q4	$19.5M	Buy	+500,000	New	+$19.6M	0.92%	30
2017 Q3	–	Sell	-425,000	Closed	-$7.17M	–	34
2017 Q2	$7.17M	Hold	425,000	–	–	0.35%	32
2017 Q1	$6.21M	Hold	425,000	–	–	0.25%	29
2016 Q4	$6.04M	Sell	425,000 -625,000	-60%	-$9.68M	0.31%	32
2016 Q3	$18.4M	Hold	1,050,000	–	–	0.81%	26
2016 Q2	$18M	Buy	+1,050,000	New	+$18.8M	0.87%	33
2016 Q1	–	Sell	-1,050,000	Closed	-$19.9M	–	56
2015 Q4	$19.9M	Buy	1,050,000 +75,000	+8%	+$1.53M	1.29%	25
2015 Q3	$18.6M	Buy	975,000 +225,000	+30%	+$7.64M	1.6%	21
2015 Q2	$34.8M	Hold	750,000	–	–	2.37%	18
2015 Q1	$32.8M	Buy	+750,000	New	+$34.9M	2.34%	20

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Camber Capital Management's ARNA Position: Q1 2019 in Review

Camber Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2019, closing a stake of 500,000 shares — an estimated $19.5M sold.

Camber Capital Management first reported a position in ARNA in Q1 2015 and held it in 10 quarters. The position peaked at $34.8M in Q2 2015. 184 funds tracked by Wall St. Rank hold ARNA as of Q1 2019.

Camber Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2019 after selling out during the quarter.
Camber Capital Management sold 500,000 Arena Pharmaceuticals Inc shares in Q1 2019, an estimated $19.5M.
Camber Capital Management first reported a position in Arena Pharmaceuticals Inc in Q1 2015 and held it in 10 quarters.
Camber Capital Management's Arena Pharmaceuticals Inc position peaked at $34.8M in Q2 2015.
184 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2019.

Based on Camber Capital Management's 13F filing for Q1 2019, filed 15 May 2019.